Searched for
RIBOCICLIB
Protect patients and patents smartlyThe Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Kerala HC says exorbitant drug prices can trigger government intervention in patented medicinesThe Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Delhi HC seeks response on Natco's patent challenge pleaThe Delhi High Court is reviewing Natco Pharma's challenge to a breast cancer drug patent. Natco alleges Novartis and Astex secured two pat...
- Novartis case: Delhi HC pulls up patent office over decade-long delay in breast cancer drug approvalThe Delhi High Court has stepped in with a firm hand, criticizing the patent office for its sluggish response to Novartis AG's 2011 patent ...
- Go on, pop the innovation pill: ₹5,000 cr push signals India’s shift from copy to createIndia's pharma sector is poised for innovation-led growth, fueled by patent expirations and government support. The ₹5,000-cr PRIP scheme a...
- Alembic Pharma gets tentative USFDA nod for breast cancer drugThe medicine is indicated for the treatment of adult patients with a certain type of advanced or metastatic breast cancer in a combination ...
- Breast cancer treatment successfully stops tumour growthMelbourne, July 28 (IANS) A breast cancer treatment developed by Australian researchers has successfully halted tumour growth for twice as ...
Load More
